Prognostic Usefulness of Sentinel Lymph Node Biopsy for Patients Who Have Clinically Node Negative, Localized, Primary Invasive Cutaneous Melanoma
Open Access
- 1 April 2011
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 147 (4) , 408-415
Abstract
The combined procedures of lymphatic mapping and sentinel lymph node biopsy (SLNB) have been devised as minimally invasive alternatives to elective lymph node dissection to identify occult metastases in patients with clinically node-negative localized primary invasive cutaneous melanoma (CM) and who might benefit from therapeutic lymph node dissection (TLND).1,2 An international randomized cohort study of patients with primary CM of intermediate thickness, the Multicenter Selective Lymphadenectomy Trial (MSLT),3 was designed to determine the survival impact of lymphatic mapping plus SLNB (and immediate TLND for positive cases), compared with nodal observation. According to this study,3 there was no significant difference in disease-specific survival when the 2 groups were compared. Retrospective studies by other groups have shown similar results.4-8Keywords
This publication has 57 references indexed in Scilit:
- Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary OutcomesJAMA, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion LymphadenectomyAnnals of Surgical Oncology, 2009
- Sentinel Lymph Node Dissection in Primary Melanoma Reduces Subsequent Regional Lymph Node Metastasis as Well as Distant Metastasis After Nodal InvolvementAnnals of Surgical Oncology, 2009
- Sentinel Lymph Node Biopsy in Cutaneous Melanoma: A Case-Control StudyAnnals of Surgical Oncology, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional StudyAnnals of Surgical Oncology, 2006
- Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patientsBritish Journal of Dermatology, 2005
- The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanomaBritish Journal of Dermatology, 2004
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992